Olimel 5.7% E 0.15 g (l-Tyrosine) Emulsion

OlimeL 5.7% E 0.15 G is an intravenous emulsion containing L-Tyrosine, designed for nutritional support. This product, manufactured by Baxter Corporation in Canada, is available in various pack sizes for flexible administration.

OlimeL 5.7% E 0.15 G is primarily used to provide essential amino acids, including L-Tyrosine, for patients who cannot obtain adequate nutrition through oral intake. This emulsion supports protein synthesis and overall nutritional health, making it suitable for individuals with specific dietary needs or metabolic conditions. What is OlimeL 5.7% E 0.15 G used for? It is commonly utilized in clinical settings to ensure proper nutritional balance and support recovery.

When administered intravenously, OlimeL 5.7% E 0.15 G provides essential amino acids that the body needs for various functions. Patients may experience improved nutritional status and support for metabolic processes. The emulsion is designed to be well-tolerated, but individual responses can vary.

OlimeL 5.7% E 0.15 G should be administered under medical supervision to ensure proper use and to monitor for any adverse reactions. It is important to follow the prescribed guidelines for administration and to store the product according to the manufacturer's instructions to maintain its efficacy and safety.

OlimeL 5.7% E 0.15 G may interact with other medications or supplements, particularly those that affect amino acid metabolism. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. Additionally, it is important to consider the compatibility of this emulsion with other intravenous solutions.